AIDS Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Life Sciences
Reports outline life sciences study findings from University of Sao Paulo
November 3rd, 2008
"HIV patients often develop alterations of the plasma lipids that may implicate in development of premature coronary artery disease. High-density lipoprotein (HDL) has all important role ill preventing atherogenesis and the aim of this study was to investigate aspects of HDL function in HIV+ patients," investigators in Sao Paulo, Brazil report. "HIV+ patients (n = 48) and healthy control Subjects (it = 45) of both sexes with similar age were Studied. Twenty-five were not being treated with antiretroviral agents. 13 were under reverse transcriptase inhibitor nucleosidic and non-nucleosidic (NRTI+NNRTI) and 10 were under NRTI + protease inhibitors (NRTI+PI) treatment....
Source: AIDS Weekly (2008-11-03)
|
